Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Oct 01, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 23,230 | -- | 23,230 |
Jun 06, 2019 |
Director
Trans History: 18
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,911 | -- | 21,911 |
Jun 06, 2019 |
Director
Trans History: 2
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,911 | -- | 21,911 |
Jun 06, 2019 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,911 | -- | 21,911 |
Jun 06, 2019 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,911 | -- | 21,911 |
Jun 06, 2019 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,911 | -- | 21,911 |
Jun 06, 2019 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,911 | -- | 21,911 |
Aug 15, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $0.38 | 20,000 |
Oct 23, 2019 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,500 | $0.85 | 19,500 |
Aug 23, 2018 |
Ten Percent Owner
Trans History: 20
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 15,000 | -- | 15,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.